Mylan NV Exercises Option Right On Aspen
20/05/2019Aspen Pharmacare said on Monday that Mylan NV had exercised an option to buy Aspen’s portfolio of prescription and over-the-counter products in Australia for 188 million Australian dollars ($130 million)..